Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Khan MA et al. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. 2012 FEMS Immunol. Med. Microbiol. pmid:22612788
Gerstein AC et al. Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. 2012 Genetics pmid:22714405
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Mima EG et al. Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. 2012 Clin. Microbiol. Infect. pmid:22731617
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Kalema N et al. Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. 2012 PLoS ONE pmid:22808020
Al-Dwairi ZN et al. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. 2012 J Prosthodont Res pmid:22841909
Caliceti C et al. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. 2012 PLoS ONE pmid:22859971
Kondo C et al. Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. 2012 J Toxicol Sci pmid:22863853
Hingston CD et al. Impact of nystatin on Candida and the oral microbiome. 2012 Crit Care pmid:22827886
Xu L et al. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. 2011 May-Jun Mol Med Rep pmid:21468584
Brito GN et al. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. 2011 Jan-Feb Braz Oral Res pmid:21271179
Mane RS et al. Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. 2011 J. Org. Chem. pmid:21381774
Shahidi-Noghabi S et al. Internalization of Sambucus nigra agglutinins I and II in insect midgut CF-203 cells. 2011 Arch. Insect Biochem. Physiol. pmid:21254203
Jeon HG et al. Analysis and functional expression of NPP pathway-specific regulatory genes in Pseudonocardia autotrophica. 2011 J. Ind. Microbiol. Biotechnol. pmid:21259033
Acar A et al. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. 2011 Burns pmid:21354707
Villa NY et al. Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets. 2011 J. Mol. Evol. pmid:22009226
Frey Tirri B Antimicrobial topical agents used in the vagina. 2011 Curr. Probl. Dermatol. pmid:21325838
Pupe CG et al. Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans. 2011 Int J Nanomedicine pmid:22114490